Annual Shareholders Equity
$130.99 M
-$235.65 M-64.27%
31 December 2023
Summary:
Nektar Therapeutics annual stockholders equity is currently $130.99 million, with the most recent change of -$235.65 million (-64.27%) on 31 December 2023. During the last 3 years, it has fallen by -$946.31 million (-87.84%). NKTR annual shareholders equity is now -92.37% below its all-time high of $1.72 billion, reached on 31 December 2018.NKTR Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$48.88 M
-$30.80 M-38.66%
30 September 2024
Summary:
Nektar Therapeutics quarterly stockholders equity is currently $48.88 million, with the most recent change of -$30.80 million (-38.66%) on 30 September 2024. Over the past year, it has dropped by -$110.48 million (-69.33%). NKTR quarterly shareholders equity is now -97.37% below its all-time high of $1.86 billion, reached on 30 June 2018.NKTR Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NKTR Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -64.3% | -69.3% |
| 3 y3 years | -87.8% | -93.9% |
| 5 y5 years | -92.4% | -96.7% |
NKTR Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -87.8% | at low | -93.9% | at low |
| 5 y | 5 years | -92.4% | at low | -96.7% | at low |
| alltime | all time | -92.4% | +245.7% | -97.4% | +154.4% |
Nektar Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $48.88 M(-38.7%) |
| June 2024 | - | $79.69 M(-37.1%) |
| Mar 2024 | - | $126.70 M(-3.3%) |
| Dec 2023 | $130.99 M(-64.3%) | $130.99 M(-17.8%) |
| Sept 2023 | - | $159.37 M(-19.1%) |
| June 2023 | - | $196.96 M(-18.2%) |
| Mar 2023 | - | $240.87 M(-34.3%) |
| Dec 2022 | $366.64 M(-46.0%) | $366.64 M(-11.1%) |
| Sept 2022 | - | $412.22 M(-10.1%) |
| June 2022 | - | $458.73 M(-24.5%) |
| Mar 2022 | - | $607.89 M(-10.5%) |
| Dec 2021 | $679.51 M(-36.9%) | $679.51 M(-15.2%) |
| Sept 2021 | - | $801.54 M(-11.4%) |
| June 2021 | - | $904.98 M(-9.0%) |
| Mar 2021 | - | $994.51 M(-7.7%) |
| Dec 2020 | $1.08 B(-23.3%) | $1.08 B(-8.0%) |
| Sept 2020 | - | $1.17 B(-6.8%) |
| June 2020 | - | $1.26 B(-3.1%) |
| Mar 2020 | - | $1.30 B(-7.8%) |
| Dec 2019 | $1.41 B(-18.2%) | $1.41 B(-5.6%) |
| Sept 2019 | - | $1.49 B(-4.4%) |
| June 2019 | - | $1.56 B(-4.7%) |
| Mar 2019 | - | $1.63 B(-4.9%) |
| Dec 2018 | $1.72 B(+1855.6%) | $1.72 B(-4.1%) |
| Sept 2018 | - | $1.79 B(-3.8%) |
| June 2018 | - | $1.86 B(+3092.0%) |
| Mar 2018 | - | $58.28 M(-33.6%) |
| Dec 2017 | $87.83 M(-0.3%) | $87.83 M(+4.4%) |
| Sept 2017 | - | $84.16 M(+2385.6%) |
| June 2017 | - | $3.39 M(-92.4%) |
| Mar 2017 | - | $44.75 M(-49.2%) |
| Dec 2016 | $88.13 M(+1270.7%) | $88.13 M(-229.9%) |
| Sept 2016 | - | -$67.85 M(+72.9%) |
| June 2016 | - | -$39.25 M(>+9900.0%) |
| Mar 2016 | - | -$275.00 K(-104.3%) |
| Dec 2015 | $6.43 M(-82.3%) | $6.43 M(-83.5%) |
| Sept 2015 | - | $39.05 M(+11.3%) |
| June 2015 | - | $35.10 M(-54.6%) |
| Mar 2015 | - | $77.31 M(+112.8%) |
| Dec 2014 | $36.33 M(-140.4%) | $36.33 M(-23.1%) |
| Sept 2014 | - | $47.22 M(-233.5%) |
| June 2014 | - | -$35.36 M(+260.5%) |
| Mar 2014 | - | -$9.81 M(-89.1%) |
| Dec 2013 | -$89.90 M(-291.2%) | -$89.90 M(+78.9%) |
| Sept 2013 | - | -$50.25 M(+23.9%) |
| June 2013 | - | -$40.55 M(+1447.7%) |
| Mar 2013 | - | -$2.62 M(-105.6%) |
| Dec 2012 | $47.02 M(-76.2%) | $47.02 M(-50.7%) |
| Sept 2012 | - | $95.33 M(-27.9%) |
| June 2012 | - | $132.28 M(-18.6%) |
| Mar 2012 | - | $162.49 M(-17.9%) |
| Dec 2011 | $197.81 M(+118.2%) | $197.81 M(-14.3%) |
| Sept 2011 | - | $230.80 M(-8.2%) |
| June 2011 | - | $251.28 M(-10.7%) |
| Mar 2011 | - | $281.24 M(+210.2%) |
| Dec 2010 | $90.66 M(-11.4%) | $90.66 M(-15.2%) |
| Sept 2010 | - | $106.95 M(-2.4%) |
| June 2010 | - | $109.53 M(+4.6%) |
| Mar 2010 | - | $104.75 M(+2.3%) |
| Dec 2009 | $102.37 M | $102.37 M(-3.5%) |
| Sept 2009 | - | $106.10 M(-18.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2009 | - | $130.60 M(-18.0%) |
| Mar 2009 | - | $159.27 M(-16.2%) |
| Dec 2008 | $190.15 M(-11.3%) | $190.15 M(+75.0%) |
| Sept 2008 | - | $108.63 M(-24.4%) |
| June 2008 | - | $143.70 M(-18.2%) |
| Mar 2008 | - | $175.76 M(-18.0%) |
| Dec 2007 | $214.44 M(-5.6%) | $214.44 M(+25.5%) |
| Sept 2007 | - | $170.90 M(-9.4%) |
| June 2007 | - | $188.68 M(-10.4%) |
| Mar 2007 | - | $210.62 M(-7.2%) |
| Dec 2006 | $227.06 M(-30.5%) | $227.06 M(-9.8%) |
| Sept 2006 | - | $251.68 M(-5.1%) |
| June 2006 | - | $265.26 M(-13.5%) |
| Mar 2006 | - | $306.81 M(-6.1%) |
| Dec 2005 | $326.81 M(-30.1%) | $326.81 M(-24.7%) |
| Sept 2005 | - | $434.10 M(+3.0%) |
| June 2005 | - | $421.32 M(-5.1%) |
| Mar 2005 | - | $444.01 M(-5.0%) |
| Dec 2004 | $467.34 M(+184.6%) | $467.34 M(-2.7%) |
| Sept 2004 | - | $480.14 M(-3.5%) |
| June 2004 | - | $497.36 M(-2.7%) |
| Mar 2004 | - | $510.94 M(+211.2%) |
| Dec 2003 | $164.19 M(-20.6%) | $164.19 M(+3.5%) |
| Sept 2003 | - | $158.59 M(-9.2%) |
| June 2003 | - | $174.67 M(-6.8%) |
| Mar 2003 | - | $187.34 M(-9.4%) |
| Dec 2002 | $206.77 M(-23.5%) | $206.77 M(-12.6%) |
| Sept 2002 | - | $236.65 M(-9.7%) |
| June 2002 | - | $262.17 M(-7.8%) |
| Mar 2002 | - | $284.25 M(+5.2%) |
| Dec 2001 | $270.31 M(-2.7%) | $270.31 M(-10.7%) |
| Sept 2001 | - | $302.58 M(-8.0%) |
| June 2001 | - | $328.83 M(+2.6%) |
| Mar 2001 | - | $320.53 M(+15.3%) |
| Dec 2000 | $277.88 M(+220.8%) | $277.88 M(+80.2%) |
| Sept 2000 | - | $154.17 M(-3.2%) |
| June 2000 | - | $159.30 M(-6.2%) |
| Mar 2000 | - | $169.88 M(+96.1%) |
| Dec 1999 | $86.63 M(-25.2%) | $86.63 M(-12.6%) |
| Sept 1999 | - | $99.14 M(-5.6%) |
| June 1999 | - | $105.08 M(-5.1%) |
| Mar 1999 | - | $110.78 M(-4.4%) |
| Dec 1998 | $115.88 M(+19.4%) | $115.88 M(+34.1%) |
| Sept 1998 | - | $86.42 M(-5.3%) |
| June 1998 | - | $91.23 M(-2.5%) |
| Mar 1998 | - | $93.53 M(-3.7%) |
| Dec 1997 | $97.09 M(+176.6%) | $97.09 M(+62.2%) |
| Sept 1997 | - | $59.84 M(-3.5%) |
| June 1997 | - | $62.02 M(-2.5%) |
| Mar 1997 | - | $63.63 M(+81.3%) |
| Dec 1996 | $35.10 M(+73.8%) | $35.10 M(+5.4%) |
| Sept 1996 | - | $33.30 M(-5.9%) |
| June 1996 | - | $35.40 M(+93.4%) |
| Mar 1996 | - | $18.30 M(-9.4%) |
| Dec 1995 | $20.20 M(+31.2%) | $20.20 M(-9.8%) |
| Sept 1995 | - | $22.40 M(-6.7%) |
| June 1995 | - | $24.00 M(-5.9%) |
| Mar 1995 | - | $25.50 M(+65.6%) |
| Dec 1994 | $15.40 M | $15.40 M(-13.0%) |
| Sept 1994 | - | $17.70 M(-5.3%) |
| June 1994 | - | $18.70 M(+274.0%) |
| Mar 1994 | - | $5.00 M |
FAQ
- What is Nektar Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Nektar Therapeutics?
- What is Nektar Therapeutics annual shareholders equity year-on-year change?
- What is Nektar Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Nektar Therapeutics?
- What is Nektar Therapeutics quarterly shareholders equity year-on-year change?
What is Nektar Therapeutics annual stockholders equity?
The current annual shareholders equity of NKTR is $130.99 M
What is the all time high annual shareholders equity for Nektar Therapeutics?
Nektar Therapeutics all-time high annual stockholders equity is $1.72 B
What is Nektar Therapeutics annual shareholders equity year-on-year change?
Over the past year, NKTR annual stockholders equity has changed by -$235.65 M (-64.27%)
What is Nektar Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of NKTR is $48.88 M
What is the all time high quarterly shareholders equity for Nektar Therapeutics?
Nektar Therapeutics all-time high quarterly stockholders equity is $1.86 B
What is Nektar Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, NKTR quarterly stockholders equity has changed by -$110.48 M (-69.33%)